The unconventional side of vaccines (Biospectrumasia) - Jul 23, 2012 - AVANT Immunotherapeutics developed a vaccine that works by eliciting neutralizing antibodies to CETP raising HDL; AFFiRiS has an atherosclerosis vaccine in pre-clinical development that induces antibodies against CETP
Review • Dyslipidemia
|
|
Vaccines against atherosclerosis are also in development. AVANT Immunotherapeutics developed a vaccine that works by eliciting neutralizing antibodies to cholesteryl ester transfer (CETP) raising high density lipoprotein. AFFiRiS also has an atherosclerosis vaccine in pre-clinical development that induces antibodies against CETP.
(IR 3)
|